Albert Bourla

Pharma

Pfizer unveils 2026 guidance, triggering 5% share-price decline

With COVID sales falling and patent protections expiring, Pfizer is forecasting its 2026 revenue to be in the range of $59.5 billion to $62.5 billion.

Kevin Dunleavy Dec 16, 2025 11:19am

Pfizer's vaccine franchises suffer sales declines in Q3

Nov 4, 2025 2:50pm

UPDATED: Pfizer offers US drug price concessions in MFN push

Sep 30, 2025 1:07pm

Is Trump’s MFN pricing order more bark than bite?

Aug 8, 2025 9:18am

Pfizer CEO espouses optimism amid MFN pricing, tariff threats

Aug 5, 2025 11:58am

The 10 highest-paid Big Pharma CEOs of 2024

Jun 16, 2025 3:00am